Physician profile
Erin E Dodge
NPI 1760403331
$1,301.53
in general payments reported to CMS, 2019-2025
25 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $112 · 2021: $111 · 2023: $368 · 2024: $178 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.10 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $226.36 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $160.91 | 2023-2025 | Viberzi, Linzess |
| Astellas Pharma US INC | $117.75 | 2019-2021 | |
| Pfizer INC. | $106.11 | 2019-2025 | |
| Lilly USA, LLC | $103.42 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $72.24 | 2019-2024 | Breztri |
| Amgen INC. | $62.85 | 2019-2023 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $53.22 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Novo Nordisk INC | $52.31 | 2020-2024 | Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $40.43 | 2020-2023 | |
| Insulet Corporation | $29.88 | 2025 | Omnipod |
| Exact Sciences Corporation | $24.70 | 2025 | Cologuard Collection Kit |
| Phadia US INC. | $24.48 | 2023 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $23.92 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $22.21 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $21.96 | 2023 | Lybalvi |
| Inspire Medical Systems, INC. | $21.69 | 2025 | Inspire |
| Genentech USA, INC. | $20.37 | 2019 | |
| Therapeuticsmd, INC. | $20.29 | 2020 | |
| Kaleo, INC. | $19.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.97 | 2019 | |
| Irhythm Technologies, INC. | $16.69 | 2024 | Zio Xt Patch |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.63 | 2020 | |
| Allergan, INC. | $13.30 | 2019 | |
| Merck Sharp & Dohme LLC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Dodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.